Prediction value of XRCC 1 gene polymorphism on the survival of ovarian cancer treated by adjuvant chemotherapy. [electronic resource]
Producer: 20130604Description: 5007-10 p. digitalISSN:- 2476-762X
- Adenocarcinoma, Clear Cell -- drug therapy
- Adenocarcinoma, Mucinous -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bleomycin -- administration & dosage
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- Cystadenocarcinoma, Serous -- drug therapy
- DNA-Binding Proteins -- genetics
- Endometrial Neoplasms -- drug therapy
- Female
- Follow-Up Studies
- Genetic Predisposition to Disease
- Humans
- Middle Aged
- Neoplasm Staging
- Ovarian Neoplasms -- drug therapy
- Polymerase Chain Reaction
- Polymorphism, Genetic -- genetics
- Prognosis
- Prospective Studies
- Survival Rate
- X-ray Repair Cross Complementing Protein 1
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.